In contrast, the methylation status of the HMGCR gene promoter regions is not shown to be associated with CHD (OR = 1.813; 95% CI, 0.829–3.965; P  = 0.134 and OR = 1.388; 95% CI, 0.572–3.371; P* = 0.469). This evidence concerns the gene HMGCR and coronary artery disorder.